key: cord-0997057-3sl5u35h
authors: Quiros-Roldan, Eugenia; Biasiotto, Giorgio; Zanella, Isabella
title: Letter to the Editor on “Bonafè M, Prattichizzo F, Giuliani A, Storci G, Sabbatinelli J, Olivieri F. Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes. Cytokine Growth Factor Rev”
date: 2020-06-04
journal: Cytokine Growth Factor Rev
DOI: 10.1016/j.cytogfr.2020.06.002
sha: 5953e4cee71a72714880d7554501f56f31148874
doc_id: 997057
cord_uid: 3sl5u35h

nan

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

We read with great interest the review article by Bonafè F et al. in Cytokine & Growth Factor Reviews [1] , which describes the main features typical of aging (inflamm-aging, immune-senescence and age-related diseases) as a partial explanation of the disproportionate COVID-19 mortality suffered by elderly men.

Patients of older age (>60 years) and with other co-morbidities such as hypertension, respiratory disease, cardiovascular disease, diabetes and chronic kidney disease are indeed found to present with more severe SARS-CoV-2 infection and have adverse outcomes.

Systemic immune activation and inflammation are also recognized as essential components in the pathogenesis of HIV infection. Despite antiretroviral therapy (ART)-related benefits on health and quality of life of HIV-infected patients, an increase in common age-related conditions occurs that may represent an accelerated aging phenotype, whereby the increased rate of complications occurs earlier than in a control group of the same age [2, 3] . The pathogenesis of these non-communicable diseases is complex but is also attributable to persistent immune activation and inflammation. This accelerated aging during HIV disease is supported by studies on DNA-methylation level, telomere length and immune-senescence while chronic immune activation is found in HIV-infected patients and is characterized by an increase in proinflammatory mediators, dysfunctional Tregs and a pattern of T-cell-senescent phenotypes, similar to those observed in the elderly.

During SARS-CoV-2 pandemic, there have been few case published reports of COVID-19 in HIV-infected persons but, surprisingly, the vast majority of cases were mild or moderate and the risk of death or admission to an intensive care unit seems lower than in general population [4] . Well-treated HIV patients who reach normal CD4 + cell level and suppressed HIV viremia may not have an increased risk for severe COVID19, but in this population, some of the conditions cited by Bonafè et al coexist that could increase their overall risk. In the large majority of European HIV cohorts, more than half of the patients are males, aged > 50 years (although HIV infection can add nearly 10 years to chronologic age due to premature aging J o u r n a l P r e -p r o o f [5] ), most are smokers and with cardiovascular diseases, hypertension and/or metabolic syndrome. Despite these well-established characteristics of HIV-infected patients, the COVID-19 pandemic seems not to particularly affect this population. Further, antiretroviral therapy (protease inhibitors or tenofovir) seems to have no significant clinical benefit for SARS-Cov-2 infection in vivo. Therefore, a panel of biomarkers of immunological/biological age may not be enough to effectively assess individual susceptibility to the adverse outcome of Sars-Cov-2 infection in HIV-infected individuals.

Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes

Comorbidities in Persons With HIV: The Lingering Challenge

Ageing and inflammation in patients with HIV infection

Clinical features and outcomes of HIV patients with coronavirus disease 2019

Premature age-related comorbidities among HIV-infected persons compared with the general population